CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

CVRx (NASDAQ: CVRX) announced its management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, Dec. 3, 2025.

The session is scheduled for 2:00 p.m. ET and will be available via a live audio webcast on the company investor relations website at ir.cvrx.com. The presentation offers investors a chance to hear management discuss recent developments and company outlook.

MINNEAPOLIS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will participate in a fireside chat at the Piper Sandler 37^th Annual Healthcare Conference on Wednesday, Dec. 3, 2025. The fireside chat is scheduled at 2:00 p.m. (ET) the same day via webcast.

A live audio webcast of the fireside chat will be available online at the investor relations page of the Company’s website at ir.cvrx.com.

About CVRx, Inc.

CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostim™ is the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. It has been certified as compliant with the EU Medical Device Regulation (MDR) and holds CE Mark approval for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit www.cvrx.com.

Investor Contact:
Mark Klausner or Mike Vallie
ICR Healthcare
443-213-0501
ir@cvrx.com 

Media Contact:
Emily Meyers
CVRx, Inc.
763-416-2853
emeyers@cvrx.com 

FAQ

When will CVRx (CVRX) present at the Piper Sandler 37th Annual Healthcare Conference?

CVRx management will present on Wednesday, Dec. 3, 2025 at 2:00 p.m. ET.

How can investors listen to the CVRx (CVRX) fireside chat on Dec. 3, 2025?

A live audio webcast will be available on the company's investor relations page at ir.cvrx.com.

What topics will CVRx (CVRX) management likely cover in the Piper Sandler fireside chat?

Management will discuss the company's recent developments, commercial progress, and outlook for cardiovascular neuromodulation.

Is the CVRx (CVRX) Piper Sandler presentation open to the public or only to conference attendees?

The fireside chat will be accessible via a public live audio webcast on the investor relations website.

Where can I find the replay of the CVRx (CVRX) Piper Sandler fireside chat after Dec. 3, 2025?

Replays are typically posted on the company's investor relations site at ir.cvrx.com after the live webcast.